Role of A1 receptors in renal sympathetic neurotransmission in the mouse kidney

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 7, 2012, Pages

  Jackson, Edwin K ^a   Cheng, Dongmei ^a   Mi, Zaichuan ^a   Verrier, Jonathan D ^a   Janesko Feldman, Keri ^a,b   Kochanek, Patrick M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenosine; Mouse kidney; Norepinephrine; Sympathetic neurotransmission

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE PHOSPHATE; INOSINE; NORADRENALIN; 1,3-DIPROPYL-8-(4-SULFOPHENYL)XANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; XANTHINE DERIVATIVE;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY PERFUSION; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RENAL SYMPATHETIC NEUROTRANSMISSION; SYMPATHETIC NERVE; VASOCONSTRICTION; ADRENERGIC SYSTEM; ANIMAL; DRUG EFFECT; GENETICS; INNERVATION; KIDNEY; MOUSE MUTANT; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ADENOSINE A1 RECEPTOR ANTAGONISTS; ANIMALS; KIDNEY; MALE; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; RECEPTOR, ADENOSINE A1; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; VASOCONSTRICTION; XANTHINES;

EID: 84867136923     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00363.2012     Document Type: Article

References (25)

1. 1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 14: 631-640, 2008.
2. 1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13: 609-617, 2007.
3. Docherty JR. Subtypes of functional 1-adrenoceptor. Cell Mol Life Sci 67: 405-417, 2010.
4. Fredholm BB, Duner-Engstrom M, Fastbom J, Hu PS, van der Ploeg I. Role of G proteins, cyclic AMP, and ion channels in the inhibition of transmitter release by adenosine. Ann NY Acad Sci 604: 276-288, 1990.
5. 1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50: 1551-1560, 2007.
6. Hansen PB, Castrop H, Briggs J, Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 14: 2457-2465, 2003.
7. Hansen PB, Hashimoto S, Briggs J, Schnermann J. Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 285: R44-R49, 2003.
8. 1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice. J Neurotrauma 27: 901-910, 2010.
9. 1 receptor antagonists in clinical research and development. Kidney Int 78: 438-445, 2010.
10. 1 receptor blocker SLV329 in experimental liver cirrhosis in rats. PLos One 6: e17891, 2011.
11. 1 receptor antagonists as diuretic/natriuretic agents. Drugs Future 27: 1057-1069, 2002.
12. Jackson EK. P1 and P2 receptors in the renal system. In: Handbook of Experimental Pharmacology Volume 151/II; Purinergic and Pryimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function, edited by Abbrachio M and Williams M. Berlin: Springer-Verlag, 2001, p. 33-71.
13. 1 receptor-mediated coincident signaling. Am J Physiol Renal Physiol 302: F466-F476, 2012.
14. Jackson EK, Ren J, Mi Z. Extracellular 2',3'-cAMP is a source of adenosine. J Biol Chem 284: 33097-33106, 2009.
15. Jacobson KA, Knutsen LJS. P1 and P2 purine and pyrimidine receptor ligands. In: Purinergic and Pyrmidinergic Signalling I, edited by Abbracchio MP and Williams M. Berlin: Springer-Verlag, 2001, p. 129-175.
16. 1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 26: 565-575, 2006.
17. Lai EY, Patzak A, Steege A, Mrowka R, Brown R, Spielmann N, Persson PB, Fredholm BB, Persson AEG. Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int 70: 690-698, 2006.
18. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
19. 1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 12: 497-502, 2003.
20. Ren J, Mi ZC, Jackson EK. Assessment of nerve stimulation-induced release of purines from mouse kidneys by tandem mass spectrometry. J Pharmacol Exp Ther 325: 920-926, 2008.
21. Selbie LA, Hill SJ. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci 19: 87-93, 1998.
22. Tofovic SP, Branch KR, Oliver RD, Magee WD, Jackson EK. Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256: 850-860, 1991.
23. Vallon V, Miracle C, Thomson S. Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 10: 176-187, 2008.
24. Welch WJ. Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert Opin Investig Drugs 11: 1553-1562, 2002.
25. Westfall DP, Todorov LD, Mihaylova-Todorova ST. ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exp Ther 303: 439-444, 2002.